로딩 중…
StockDiggingStockDigging

Danaher Corporation

DHR· NYSE
$177.23-0.30%
2026-06-18

Price Chart

Danaher Corporation-8.42%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$125.44B
Revenue$24.78B
Net Income$3.69B
Total Assets$83.54B
Net Assets$52.95B
Employees58,000
Value
P/E34.00x
P/B2.37x
PEG4.33x
P/S5.06x
EV/EBITDA20.66x
FCF Yield4.22%
Profitability
ROE6.97%
ROA4.42%
Op. Margin20.95%
Revenue Growth3.66%
Earnings Growth7.86%
Financial Health
Debt Ratio57.78%
Total Debt$18.48B
FCF$5.29B
Cash$5.70B
Current Ratio1.87x
Net Debt/EBITDA1.91x
Dividend
Div. Yield0.73%
Div. Growth18.15%
Performance
1Y Return-8.42%
1M Return6.10%
From 52W High-27.01%
1Y MDD-33.11%
Trading
Volume3,000,527 shares
Trading Value$530M
Per Share
EPS$5.11
BPS$74.27

Company Info

CEO Mr. Rainer M. Blair
Employees 58,000
HQ Washington, United States

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.